Hepatitis Monthly

Published by: Kowsar

Risk Factors of HCV Seroconversion in Hemodialysis Patients in Tabriz, Iran

Mohammad Hossein Somi 1 , Jalal Etemadi 2 , Morteza Ghojazadeh 1 , Sara Farhang 3 , Mehrasa Faramarzi 1 , Sanaz Foroutan 1 and Maryam Soleimanpour 1 , *
Authors Information
1 Liver and Gastrointestinal Disease Research Center, Tabriz University of Medical Sciences, Tabriz, IR Iran
2 Chronic Kidney Diseases Research Center, Tabriz University of Medical Sciences, Tabriz, IR Iran
3 Cliniclal Psychiatry Research Center, Tabriz University of Medical Sciences, Tabriz, IR Iran
Article information
  • Hepatitis Monthly: June 01, 2014, 14 (6); e17417
  • Published Online: June 1, 2014
  • Article Type: Research Article
  • Received: January 6, 2014
  • Revised: March 16, 2014
  • Accepted: April 20, 2014
  • DOI: 10.5812/hepatmon.17417

To Cite: Somi M H, Etemadi J, Ghojazadeh M, Farhang S, Faramarzi M, et al. Risk Factors of HCV Seroconversion in Hemodialysis Patients in Tabriz, Iran, Hepat Mon. 2014 ; 14(6):e17417. doi: 10.5812/hepatmon.17417.

Abstract
Copyright © 2014, Kowsar Corp. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Patients and Methods
4. Results
5. Discussion
Acknowledgements
Footnotes
References
  • 1. Global surveillance and control of hepatitis C. Report of a WHO Consultation organized in collaboration with the Viral Hepatitis Prevention Board, Antwerp, Belgium. J Viral Hepat. 1999; 6(1): 35-47[PubMed]
  • 2. Trinks J, Gadano A, Argibay P. Evolving trends in the hepatitis C virus molecular epidemiology studies: from the viral sequences to the human genome. Epidemiol Res Int. 2012; 2012: 10[DOI]
  • 3. Thomas DB, Mangan RL. Nontarget impact of spinosad GF-120 bait sprays for control of the Mexican fruit fly (Diptera: Tephritidae) in Texas citrus. J Econ Entomol. 2005; 98(6): 1950-6[PubMed]
  • 4. U. S. Public Health Service . . Updated U.S. Public Health Service Guidelines for the Management of Occupational Exposures to HBV, HCV, and HIV and Recommendations for Postexposure Prophylaxis. MMWR Recomm Rep. 2001; 50: 1-52[PubMed]
  • 5. Yen T, Keeffe EB, Ahmed A. The epidemiology of hepatitis C virus infection. J Clin Gastroenterol. 2003; 36(1): 47-53[PubMed]
  • 6. Strader DB, Wright T, Thomas DL, Seeff LB, American Association for the Study of Liver D. Diagnosis, management, and treatment of hepatitis C. Hepatology. 2004; 39(4): 1147-71[DOI][PubMed]
  • 7. Seaworth BJ, Garrett LE, Stead WW, Hamilton JD. Non-A, non-B hepatitis and chronic dialysis--another dilemma. Am J Nephrol. 1984; 4(4): 235-9[PubMed]
  • 8. Rahnavardi M, Hosseini Moghaddam SM, Alavian SM. Hepatitis C in hemodialysis patients: current global magnitude, natural history, diagnostic difficulties, and preventive measures. Am J Nephrol. 2008; 28(4): 628-40[DOI][PubMed]
  • 9. Alavian SM, Einollahi B, Hajarizadeh B, Bakhtiari S, Nafar M, Ahrabi S. Prevalence of hepatitis C virus infection and related risk factors among Iranian haemodialysis patients. Nephrology (Carlton). 2003; 8(5): 256-60[PubMed]
  • 10. Alavian SM, Adibi P, Zali MR. Hepatitis C virus in Iran: Epidemiology of an emerging infection. Arch Iran Med. 2005; 8(2): 84-90
  • 11. Somi MH, Ardalan MR, Sokhanvar H, Farhang S, Pouri A. Hepatitis C virus infection in dialysis centers of Tabriz, Iran: a multicenter study. Arch Clin Infect Dis. 2007; 2(1)
  • 12. Dienstag JL, Stevens CE, Szmuness W. Non-A non-B Hepatitis.. 1981; : 119-37
  • 13. Somi MH, Keivani H, Ardalan MR, Farhang S, Pouri AA. Hepatitis C virus genotypes in patients with end-stage renal disease in East Azerbaijan, Iran. Saudi J Kidney Dis Transpl. 2008; 19(3): 461-5[PubMed]
  • 14. Koirala SR, Singh RP, Malla RR, Khakurel S. Prevalence of Hepatts b, Hepatts c and HIV Infections among chronic Renal Failure Patents on Hemodialysis. Post-Graduate Med J NAMS. 2009; 9(2): 6-13
  • 15. Alter MJ, Kruszon-Moran D, Nainan OV, McQuillan GM, Gao F, Moyer LA, et al. The prevalence of hepatitis C virus infection in the United States, 1988 through 1994. N Engl J Med. 1999; 341(8): 556-62[DOI][PubMed]
  • 16. Fabrizi F, Raffaele L, Bacchini G, Guarnori I, Pontoriero G, Erba G, et al. Antibodies to hepatitis C virus (HCV) and transaminase concentration in chronic haemodialysis patients: a study with second-generation assays. Nephrol Dial Transplant. 1993; 8(8): 744-7[PubMed]
  • 17. Hardy NM, Sandroni S, Danielson S, Wilson WJ. Antibody to hepatitis C virus increases with time on hemodialysis. Clin Nephrol. 1992; 38(1): 44-8[PubMed]
  • 18. Sandhu J, Preiksaitis JK, Campbell PM, Carriere KC, Hessel PA. Hepatitis C prevalence and risk factors in the northern Alberta dialysis population. Am J Epidemiol. 1999; 150(1): 58-66[PubMed]
  • 19. Sampietro M, Badalamenti S, Salvadori S, Corbetta N, Graziani G, Como G, et al. High prevalence of a rare hepatitis C virus in patients treated in the same hemodialysis unit: evidence for nosocomial transmission of HCV. Kidney Int. 1995; 47(3): 911-7[PubMed]
  • 20. Knudsen F, Wantzin P, Rasmussen K, Ladefoged SD, Lokkegaard N, Rasmussen LS, et al. Hepatitis C in dialysis patients: relationship to blood transfusions, dialysis and liver disease. Kidney Int. 1993; 43(6): 1353-6[PubMed]
  • 21. Dentico P, Buongiorno R, Volpe A, Carlone A, Carbone M, Manno C, et al. Prevalence and incidence of hepatitis C virus (HCV) in hemodialysis patients: study of risk factors. Clin Nephrol. 1992; 38(1): 49-52[PubMed]
  • 22. van der Poel CL, Reesink HW, Schaasberg W, Leentvaar-Kuypers A, Bakker E, Exel-Oehlers PJ, et al. Infectivity of blood seropositive for hepatitis C virus antibodies. Lancet. 1990; 335(8689): 558-60[PubMed]
  • 23. Hayashi J, Kishihara Y, Yamaji K, Yoshimura E, Kawakami Y, Akazawa K, et al. Transmission of hepatitis C virus by health care workers in a rural area of Japan. Am J Gastroenterol. 1995; 90(5): 794-9[PubMed]
  • 24. Shaheen FA, Huraib SO, Al-Rashed R, Aldrees A, Arif M, Al Jeffry M, et al. Prevalence of hepatitis C antibodies among hemodialysis patients in the Western province of saudi arabia. Saudi J Kidney Dis Transpl. 1995; 6(2): 136-9[PubMed]
  • 25. Huraib S, al-Rashed R, Aldrees A, Aljefry M, Arif M, al-Faleh FA. High prevalence of and risk factors for hepatitis C in haemodialysis patients in Saudi Arabia: a need for new dialysis strategies. Nephrol Dial Transplant. 1995; 10(4): 470-4[PubMed]
  • 26. Vitale C, Tricerri A, Marangella M, Vacha GM, Giorcelli G, Marini C, et al. Epidemiology of hepatitis C virus infection in dialysis units: first-versus second-generation assays. Nephron. 1993; 64(2): 315-6[PubMed]
  • 27. Ahmetagic S, Muminhodzic K, Cickusic E, Stojic V, Petrovic J, Tihic N. Hepatitis C infection in risk groups. Bosn J Basic Med Sci. 2006; 6(4): 13-7[PubMed]
  • 28. Ansar MM, Kooloobandi A. Prevalence of hepatitis C virus infection in thalassemia and haemodialysis patients in north Iran-Rasht. J Viral Hepat. 2002; 9(5): 390-2[PubMed]
  • 29. Al-Jamal M, Al-Qudah A, Al-Shishi KF, Al-Sarayreh A, Al-Quraan L. Hepatitis C virus (HCV) infection in hemodialysis patients in the south of Jordan. Saudi J Kidney Dis Transpl. 2009; 20(3): 488-92[PubMed]
  • 30. Pereira BJ. Hepatitis C in organ transplantation: its significance and influence on transplantation policies. Curr Opin Nephrol Hypertens. 1993; 2(6): 912-22[PubMed]
  • 31. Alavian SM. Re: posttransplant diabetes mellitus in kidney allograft recipients at Shaheed Hasheminejad Hospital. Iran J Kidney Dis. 2008; 2(2): 110-1[PubMed]
  • 32. Alavian SM, Hajarizadeh B, Nematizadeh F, Larijani B. Prevalence and determinants of diabetes mellitus among Iranian patients with chronic liver disease. BMC Endocr Disord. 2004; 4(1): 4[DOI][PubMed]
  • 33. Saberi HR, Moravveji AR, Fakharian E, Kashani MM, Dehdashti AR. Prevalence of metabolic syndrome in bus and truck drivers in Kashan, Iran. Diabetol Metab Syndr. 2011; 3(1): 8[DOI][PubMed]
  • 34. Jadoul M, Cornu C, van Ypersele de Strihou C. Incidence and risk factors for hepatitis C seroconversion in hemodialysis: a prospective study. The UCL Collaborative Group. Kidney Int. 1993; 44(6): 1322-6[PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments